- recruitingPHASE1, PHASE2
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
This study is testing a new medicine called AZD8205, by itself or with other cancer drugs. It's for people with advanced cancers like breast, ovarian, or lung cancer, to see if it's safe and helps shrink tumours.
United States · Australia · Belgium - ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3 Study to Evaluate Zimberelimab (AB122) Combined with Domvanalimab (AB154) Compared to Pembrolizumab in Front-Line, PD-L1-High, Locally Advanced or Metastatic Non-Small Cell Lung Cancer
This study is looking at a new combination of medicines to treat a serious type of lung cancer. It compares two new drugs called zimberelimab and domvanalimab, given together, against a standard treatment called pembrolizumab, to see if the new combination helps people live longer.
Ireland · Spain · France